Found: 11
Select item for more details and to access through your institution.
Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin.
- Published in:
- Human Molecular Genetics, 2006, v. 15, n. 20, p. 3041, doi. 10.1093/hmg/ddl246
- By:
- Publication type:
- Article
Neuronal Activity-Induced Sterol Regulatory Element Binding Protein-1 (SREBP1) is Disrupted in Dysbindin-Null Mice-Potential Link to Cognitive Impairment in Schizophrenia.
- Published in:
- Molecular Neurobiology, 2017, v. 54, n. 3, p. 1699, doi. 10.1007/s12035-016-9773-x
- By:
- Publication type:
- Article
Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer's disease and tauopathies.
- Published in:
- Acta Neuropathologica, 2014, v. 128, n. 5, p. 679, doi. 10.1007/s00401-014-1328-5
- By:
- Publication type:
- Article
Akt1 deficiency in schizophrenia and impairment of hippocampal plasticity and function.
- Published in:
- Hippocampus, 2012, v. 22, n. 2, p. 230, doi. 10.1002/hipo.20887
- By:
- Publication type:
- Article
Anti-diabetic drugs protect the brain from defective insulin signaling caused by Alzheimer's toxic Aß oligomers
- Published in:
- 2012
- By:
- Publication type:
- Abstract
Brain insulin resistance demonstrated in Alzheimer's disease is closely associated with elevated IRS-1 pS and cognitive deficits
- Published in:
- 2011
- By:
- Publication type:
- Abstract
Synaptic Dysbindin-1 Reductions in Schizophrenia Occur in an Isoform-Specific Manner Indicating Their Subsynaptic Location.
- Published in:
- PLoS ONE, 2011, v. 6, n. 3, p. 1, doi. 10.1371/journal.pone.0016886
- By:
- Publication type:
- Article
An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers.
- Published in:
- Journal of Clinical Investigation, 2012, v. 122, n. 4, p. 1339, doi. 10.1172/JCI57256
- By:
- Publication type:
- Article
Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.
- Published in:
- Journal of Clinical Investigation, 2012, v. 122, n. 4, p. 1316, doi. 10.1172/JCI59903
- By:
- Publication type:
- Article
Olfactory epithelium amyloid-beta and paired helical filament-tau pathology in Alzheimer disease.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Olfactory epithelium amyloid-β and paired helical filament-tau pathology in Alzheimer disease.
- Published in:
- Annals of Neurology, 2010, v. 67, n. 4, p. 462, doi. 10.1002/ana.21910
- By:
- Publication type:
- Article